Assistant Professor
University of British Columbia
Vancouver, British Columbia, Canada
Dr. Stephanie Sellers is an Assistant Professor in the Division of Cardiology at the University of British Columbia and Director of the Cardiovascular Translational Laboratory at St. Paul's Hospital in Vancouver. As a vascular biologist, her primary research expertise in understanding mechanisms of dysfunction and degeneration of bioprosthetic heart valves and imaging related to these disease processes. Her labaoratory also specializes in bench testing and modeling to understand valve replacement.
Disclosure(s): Abbott: Consultant (Ongoing); Anteris: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Edward Lifesciences: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Excision Medical: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Stock options (Ongoing); Medtronic: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Vivitro Labs: Grant/Research Support (Ongoing)
Saturday, March 8, 2025
9:51 AM – 9:59 AM ET
Round Table Discussion | Imaging the Aortic Valve
Saturday, March 8, 2025
11:11 AM – 11:30 AM ET
Sunday, March 9, 2025
8:00 AM – 9:45 AM ET
Why Valves Fail and Can We Do Anything About It? | Data from the Bench
Sunday, March 9, 2025
9:12 AM – 9:20 AM ET
Panel Discussion | What Do We Need to Know on Lifetime Management?
Sunday, March 9, 2025
9:28 AM – 9:45 AM ET
Valve Degeneration | Important Aspects to Consider in VIV and Redo-TAVR
Sunday, March 9, 2025
10:09 AM – 10:17 AM ET
Panel Discussion | Considerations for TAV in TAV versus Explant
Sunday, March 9, 2025
10:49 AM – 11:15 AM ET
Subclinical HALT | A Driver of Bioprosthetic Degeneration or a Distraction?
Monday, March 10, 2025
1:56 PM – 2:04 PM ET
Panel Discussion | Prevalence Impact and Management of HALT and Valve Thrombosis
Monday, March 10, 2025
2:12 PM – 2:30 PM ET